Dr Talha Munir

Dr Talha Munir is a Consultant Haematologist at Leeds Teaching Hospitals NHS Trust. He graduated in 2002 from King Edward Medical College, Lahore, Pakistan, and finished his initial training in Pakistan. Talha has worked in the NHS since 2004 and completed his haematology training in Nottingham, in 2012. Talha’s main clinical and research interests are in CLL, particularly in the assessment of the mechanism of action of novel targeted therapies. He has acquired his PhD from University of Leeds in 2022 and is part of the research group involved in CLL trials. His other clinical interests include the management of patients with aplastic anaemia and paroxysmal nocturnal haemoglobinuria (PNH), and he is one of the PNH consultants working in the PNH National Service, Leeds. Talha also has a special interest in the management of adult histiocytic disorders, especially Langerhans’ cell histiocytosis (LCH) and Erdheim–Chester disease. He is the principal investigator and sub-investigator for the NCRI CLL phase II and III clinical trials in the UK and is involved in multiple NCRI and non-NCRI studies at Leeds Teaching Hospitals, where he has contributed to the development of an impressive trial portfolio. He is the deputy chair of UK NCRI CLL sub-group.

1. Chronic lymphocytic leukemias 2. Low grade T-cell leukemiaa 3. Low grade lymphoma including marginal zone lymphomas and Waldenstrom's macroglobinemia 4. Bone marrow failure including aplastic anaemia and PNH 5.  Histiocytic disorders 6.  General Haematology